Glucagon Receptor (GCGR) Antibody
260€ (50 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Glucagon Receptor (GCGR) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx214221
tested applications
ELISA, WB, IHC
Description
GCGR Antibody is a Rabbit Polyclonal against GCGR.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Glucagon Receptor (GCGR) |
| Host | Rabbit |
| Reactivity | Human, Mouse, Rat |
| Recommended Dilution | ELISA: 1/1000 - 1/2000, WB: 1/200 - 1/1000, IHC: 1/50 - 1/200. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purification | Antigen Affinity Chromatography. |
| Size 1 | 50 µl |
| Size 2 | 100 µl |
| Form | Liquid |
| Tested Applications | ELISA, WB, IHC |
| Buffer | PBS, pH 7.4, containing 0.05% NaN3 and 40% Glycerol. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | P47871 |
| Gene ID | 2642 |
| Alias | GCGR,GGR,GL-R,GR,MVAH |
| Background | Antibody anti-GCGR |
| Status | RUO |
Descripción
GCGR is a G protein-coupled receptor activated by glucagon, a hormone secreted by pancreatic α-cells during fasting to maintain blood glucose levels. GCGR is predominantly expressed in the liver, where its activation stimulates glycogenolysis and gluconeogenesis, increasing glucose production to prevent hypoglycemia. GCGR signaling activates the cAMP/PKA pathway, leading to the mobilization of glucose stores and fatty acid oxidation. Beyond its role in glucose homeostasis, GCGR is involved in lipid metabolism, ketogenesis, and energy balance. Dysregulation of GCGR contributes to hyperglycemia in conditions such as type 2 diabetes, where elevated glucagon levels exacerbate glucose production. GCGR is also expressed in extrahepatic tissues like the heart and kidney, where it plays roles in cardiovascular function and energy expenditure. GCGR antagonists are being developed as therapeutic strategies to reduce hepatic glucose output and improve glycemic control in diabetes. Additionally, GCGR agonism has been explored for weight loss and fatty liver disease due to its effects on energy balance. GCGR is a central regulator of glucose and energy metabolism, making it a key target for metabolic disease treatment.
Related Products
Glucagon Receptor (GCGR) Antibody
This product is currently in development. The lead time for this product may be several months. Please contact us at
Ver Producto